2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$10.85+$0.16 (+1.46%)
Price as of Jun 23, 2026 5:10 PM EDT- $852.6MMarket Cap
- 12.88%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$10.85+$0.16 (+1.46%)
Earnings Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 8.30% | ||
12-Month Momentum | 13.92% | ||
3-Month Risk Adjusted Momentum | 32.41% | ||
12-Month Risk Adjusted Momentum | 23.29% |
True Yield
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.03% | ||
Net Debt Paydown Yield | 5.86% |
Financial Health Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |